Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Blood red petri-dish in the hand of a researcher with bacterial colonies grown on the plate.

Prof Paresh Vyas and his team are investigating haematopoietic stem cells (HSCs) and clonal haematopoiesis (CH), associated with cardiovascular disease and blood cancers. They have been collecting bone marrow samples from otherwise well patients having hip-replacement operations to further understand the mechanisms involved to help develop targeted therapies.

More recently the team have also been studying patients with COVID-19, to understand if CH has an impact on the clinical course of COVID-19. Find out more about this research on the Cancer Research UK Oxford Centre's website.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.

Dr Noemi Roy awarded Medical Sciences Division public engagement seed funding

Dr Noemi Roy has received funding in the 2020-21 round of the Public Engagement with Research Seed Fund as one of seven projects for innovative work to engage the public with medical research.

Developing a rapid and cost-effective way to identify newborns at risk of leukaemia

MRC WIMM researchers have developed a new method to quickly identify cancerous cells in babies at risk of leukaemia. The team hope that the new protocol could make rapid testing more accessible for clinical laboratories around the globe.